pCAGGS_VP30_EBOV Citations (3)

Originally described in: An RNA polymerase II-driven Ebola virus minigenome system as an advanced tool for antiviral drug screening.
Nelson EV, Pacheco JR, Hume AJ, Cressey TN, Deflube LR, Ruedas JB, Connor JH, Ebihara H, Muhlberger E Antiviral Res. 2017 Aug 12;146:21-27. doi: 10.1016/j.antiviral.2017.08.005. PubMed Journal

Articles Citing pCAGGS_VP30_EBOV

Articles
A Chimeric Lloviu Virus Minigenome System Reveals that the Bat-Derived Filovirus Replicates More Similarly to Ebolaviruses than Marburgviruses. Manhart WA, Pacheco JR, Hume AJ, Cressey TN, Deflube LR, Muhlberger E. Cell Rep. 2018 Sep 4;24(10):2573-2580.e4. doi: 10.1016/j.celrep.2018.08.008. PubMed Associated Plasmids pCAGGS_VP30_MARV pCAGGS_L_MARV p2,0_3M5M_eGFP p2,0_3M5M_luciferase
Development of an EBOV MiniG plus system as an advanced tool for anti-Ebola virus drug screening. Hsu CJ, Chen CH, Chen WT, Liu PC, Chang TY, Lin MH, Chen CC, Chen HY, Huang CH, Cheng YH, Sun JR. Heliyon. 2023 Nov 11;9(11):e22138. doi: 10.1016/j.heliyon.2023.e22138. eCollection 2023 Nov. PubMed
Hippo signaling pathway regulates Ebola virus transcription and egress. Liang J, Djurkovic MA, Leavitt CG, Shtanko O, Harty RN. Nat Commun. 2024 Aug 13;15(1):6953. doi: 10.1038/s41467-024-51356-z. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.